You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Generics
Cipla launches generic liraglutide injection in the US
Login
Username:

Password:


Related Headlines

Breckenridge Pharmaceutical launches Pomalidomide Capsules in US market

Cipla launches generic liraglutide injection in the US

Arna Pharma signs MOU with Slate Run Pharmaceuticals

STADA and Bio-Thera Solutions receive European marketing authorisation for Gotenfia (golimumab)

DifGen Pharmaceuticals' Fluorometholone Ophthalmic Suspension, 0.1% receives FDA approval

Viatris names new chief legal officer

Alvotech signs biosimilar supply and commercialisation deals with Sandoz

InSysBio agrees new collaborative project with BeOne Medicines

MS Pharma enters strategic partnership with Hetero Group

Apiject to open new generic injectable drug manufacturing facility in Apex, NC

Sun Pharma announces US availability of UNLOXCYT (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma

Bionpharma and STEERLife's Etravirine tablets approved by US FDA

ScinoPharm Taiwan secures first US FDA approval for complex multiple sclerosis generic

ScinoPharm Taiwan's Glatiramer Acetate Injection approved by US FDA

International Isotopes Inc to change name to Radnostix Inc

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026